Enterovirus 71 type epitope as well as antibody and application and vaccine thereof

An antigenic epitope, enterovirus technology, applied in the fields of molecular biology and immunology, to achieve the effect of high neutralization titer

Active Publication Date: 2015-07-22
CHANGCHUN BCHT BIOTECH +1
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Specifically, the currently screened EV71 virus epitopes are mainly concentrated on VP1 and VP2, while VP3 epitopes and spatial conformational epitopes are rarely reported.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enterovirus 71 type epitope as well as antibody and application and vaccine thereof
  • Enterovirus 71 type epitope as well as antibody and application and vaccine thereof
  • Enterovirus 71 type epitope as well as antibody and application and vaccine thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] A fragment of the nucleotide sequence shown in SEQ ID NO: 2 was constructed into the Noru P particle plasmid expression vector PET28a-P domain

[0064] Primers were designed as follows:

[0065]

[0066] GCGGCCGC is the Not I restriction site, CCATGG is the Nco I restriction site, CTCGAG is the Xho I restriction site, and additional GCs are added to avoid frameshift mutations. Obtain the PCR product fragment of the target gene by overlapping PCR, recover the PCR product fragment of the target gene and connect it to the amplified plasmid Peasy-Blunt, transform Escherichia coli, screen positive transformants, extract the plasmid after culture, and treat the plasmid with NcoI and XhoI double enzymes. The original plasmid PET28a-P domain that had been digested with NcoI and XhoI was ligated with T4 ligase to obtain the expression plasmid. The expression plasmid construction process is as follows figure 1 shown.

[0067] The expression plasmid was transformed into expr...

Embodiment 2

[0071] Take 1 L of antigen-presenting cells induced in Example 1, blow evenly with 80ml of equilibrium solution (20mM Tris, 0.5M NaCl, [pH 8.0]), sonicate for 40min at 4°C, sonicate for 5s and stop for 5s, and keep the precipitate at 16000rpm for 30min. Urea balance solution treatment (8M urea, 20mM Tris, 0.5M NaCl, [pH 8.0]). Stir overnight at 4°C, then keep the supernatant at 10,000rpm for 30min the next day, and present it to the nickel ion affinity layer suction column. The eluent is urea equilibrium solution containing imidazole, and the final elution gradient of the target protein is 200mM imidazole to obtain the fusion protein. Use the same method to purify the control strain expressing the control protein.

[0072] respectively by SDS-PAGE ( Figure 2-a ), western blot( Figure 2-b ), analysis of two-color infrared laser imaging system ( Figure 2-c ) to identify the fusion protein and the control protein, and the two-color infrared laser imaging system quantifies t...

Embodiment 3

[0075] The fusion protein that embodiment 2 makes and AL (OH) 3 The adjuvant is mixed, and the mass ratio of the fusion protein to AL(OH)3 is 25 μg:200 μg / dose to prepare a vaccine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to the technical field of molecular biology and immunology and particularly relates to an enterovirus 71 type epitope, an antibody, application and a vaccine thereof. The epitope of the EV71 virus is located on a coat protein VP3 of the EV71 virus and is capable of specifically identifying the EV71 virus; besides, the epitope is presented through a PP carrier to cause a high neutralizing titer, and the serum after immunity is capable of effectively protecting the young rat from EV71 virus infection. The neutrality detection result of the polyclone on each EV71 subtype pseudovirus shows that the polyclonal antibody provided by the invention has high and broad-spectrum neutralizing titer. In addition, the passive protection and the maternal vertical protection experiments prove that the polyclonal antibody provided by the invention can completely protect the young rat from EV71virus infection.

Description

technical field [0001] The invention relates to the technical fields of molecular biology and immunology, in particular to an enterovirus type 71 epitope, an antibody, its application and a vaccine. Background technique [0002] Hand, foot and mouth disease (HFMD) is a global infectious disease, enterovirus 71 (Enterovirus 71, EV71) and Coxsackievirus A16 (Coxsackievirus A16, CA16) are hand, foot and mouth disease (Hand, Foot and mouth disease (HFMD) is the main pathogen. Since EV71 was first isolated in the United States in 1969, the prevalence of HFMD caused by EV71 infection has been reported in Australia, Japan, Brazil, the Netherlands, Malaysia, and Taiwan. On May 2, 2008, the Chinese Ministry of Health listed HFMD as a Class C infectious disease. Virus particles of natural enteroviruses are spherical structures with icosahedral stereosymmetry, no envelope and protrusions, and the diameter is about 24-30 nm. Enteroviruses mainly infect children under the age of 5. Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08C07K19/00C07K16/10C12N15/41C12N15/70C12N1/21G01N33/68G01N33/569A61K39/125A61K39/42A61P31/14
Inventor 姜春来孔维蒋丽萍孙世洋
Owner CHANGCHUN BCHT BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap